Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 3074-3080
Published online May 21, 2008. doi: 10.3748/wjg.14.3074
Published online May 21, 2008. doi: 10.3748/wjg.14.3074
Table 1 Clinicopathologic characteristics of patients with gastric and colorectal adenocarcinoma
| Characteristics | Patients (n) | ||
| Gastric cancer | Colorectal cancer | ||
| Sex | Male | 29 | 24 |
| Female | 18 | 21 | |
| Age (yr) | ≤ 60 | 21 | 31 |
| > 60 | 26 | 14 | |
| Differentiation grade | G1/Broders’ I | 2 | 4 |
| G2/Broders’ II | 23 | 34 | |
| G3/Broders’ III & IV | 22 | 7 | |
| Stage | TNM I/Duke’s A | 4 | 5 |
| TNM II/Duke’s B | 15 | 16 | |
| TNM III/Duke’s C | 16 | 14 | |
| TNM IV/Duke’s D | 12 | 10 | |
-
Citation: Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Detection of
RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008; 14(19): 3074-3080 - URL: https://www.wjgnet.com/1007-9327/full/v14/i19/3074.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3074